Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by robinee3on Apr 21, 2011 6:11pm
449 Views
Post# 18472510

Marché OTC

Marché OTC 
 Bonjour à tous,

 Je voudrais savoir si j'ai bien compris la dernière intervention de Rusty. En date du 31 Mars 2011,
 il y a eu 3,6 millions actions qui ont été transigé sur le marché OTC américain.
 Si je comprend bien, depuis environ 1 an, il y aurait au total environ 3,6 millions d'actions qui aurait transféré
 du marché canadien TSX au marché Américain OTC. Est-ce que c'est exact ?
 Si c'est exact, ça démontre donc tous l'intérêt du marché américain envers TH.
 Merci à ceux qui voudront éclaircir mon incompréhension pour le marché OTC que je ne connais pas.

 Robinee3
Bullboard Posts